糖尿病護理設備市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Diabetes Care Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年11月05日 | 出版商:

Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球糖尿病護理設備市場達到 451 億美元，預計 2024 年至 2032 年複合年成長率為 11.4%。連續血糖監測儀(CGM)、胰島素幫浦、智慧型胰島素筆、注射器和刺血針。

市場分為胰島素輸送設備、血糖監測設備、注射器和其他工具。血糖監測設備，包括自我監測血糖儀、連續血糖監測儀、試紙和刺血針，是最大的細分市場。這些設備在 2023 年將佔據重要佔有率，預計複合年成長率為 11.6%。這些設備對於糖尿病患者至關重要，使他們能夠追蹤血糖水平並就飲食、運動和胰島素劑量做出明智的決定。持續監測有助於預防低血糖和高血糖，讓使用者更好地控制血糖水平，並增強有效管理糖尿病的能力。

該市場還按最終用戶類別進行細分，包括醫院、門診手術中心、診斷中心、家庭護理機構等。醫院是最大的最終用戶部分，佔據了顯著的市場佔有率。這些醫療機構是糖尿病照護不可或缺的一部分，提供包括診斷、治療和持續監測在內的全面服務。醫院需要各種糖尿病護理設備，包括血糖儀、胰島素幫浦、CGM 和胰島素筆，這些設備已嵌入患者護理方案中以支援有效的糖尿病管理。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	451 億美元
預測值	1186 億美元
複合年成長率	11.4%

北美糖尿病護理設備市場以美國為主導，該國在 2023 年的收入最高。美國強勁的醫療保健支出在推動這些設備的採用方面發揮關鍵作用，因為它使人們能夠獲得最先進的治療選擇。此外，有利的監管環境支持新糖尿病護理技術的開發和批准，促進市場內的創新和成長。

總體而言，在糖尿病盛行率不斷上升、有效管理解決方案意識不斷增強以及醫療技術不斷進步的推動下，糖尿病護理設備市場有望顯著成長。

產業生態系統分析
產業影響力
- 成長動力
  - 全球糖尿病盛行率不斷上升
  - 糖尿病護理設備不斷進步的技術
  - 增加公共和私人組織對糖尿病護理的投資
- 產業陷阱與挑戰
  - 糖尿病照護設備成本高昂
  - 嚴格的監管框架
成長潛力分析
監管環境
技術景觀
報銷場景
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
血糖監測設備
- 自我監測血糖儀
- 連續血糖監測儀
- 測試條
- 柳葉刀
胰島素輸送裝置
- 胰島素幫浦
  - 管式幫浦
  - 無內胎幫浦
- 鋼筆
  - 可重複使用的
  - 一次性的
- 筆針
  - 標準
  - 安全
- 注射器
- 其他胰島素輸送裝置

第 6 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
醫院
門診手術中心
診斷中心
居家護理
其他最終用戶

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 比利時
- 丹麥
- 芬蘭
- 挪威
- 立陶宛
- 拉脫維亞
- 愛沙尼亞
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 土耳其
- 埃及
- 以色列
- 科威特
- 卡達

第 8 章：公司簡介

Abbott Laboratories
ARKRAY
Ascensia Diabetes Care Holding
B. Braun Melsungen
Becton, Dickinson and Company
Bionime Corporation
DarioHealth Corp.
Dexcom
Dr. Reddy's Laboratories
Eli Lilly and Company
F. Hoffmann-La Roche
Insulet Corporation
Medtronic
Nova Biomedical
Novo Nordisk
Pendiq
Platinum Equity Advisors
Sanofi
Sinocare
Tandem Diabetes Care
Ypsomed Holding

簡介目錄

Product Code: 3250

The Global Diabetes Care Devices Market reached USD 45.1 billion in 2023 and is projected to grow at a CAGR of 11.4% from 2024 to 2032. This market includes a wide range of devices designed to support individuals in managing their blood sugar levels and insulin therapy effectively, such as blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, smart insulin pens, syringes, and lancets.

The market is categorized into insulin delivery devices, blood glucose monitoring devices, syringes, and other tools. Blood glucose monitoring devices, which include self-monitoring blood glucose meters, continuous glucose monitors, testing strips, and lancets, represent the largest segment. These devices accounted for a significant share in 2023 and are expected to grow at 11.6% CAGR. These devices are essential for people with diabetes, allowing them to track their blood sugar levels and make informed decisions regarding diet, exercise, and insulin doses. Continuous monitoring helps prevent hypoglycemia and hyperglycemia, giving users greater control over their glucose levels and enhancing their ability to manage diabetes effectively.

The market is also segmented by end-user categories, which include hospitals, ambulatory surgical centers, diagnostic centers, homecare settings, and others. Hospitals are the largest end-user segment, accounting for a notable market share. These healthcare institutions are integral to diabetes care, offering comprehensive services that include diagnosis, treatment, and continuous monitoring. Hospitals require a diverse array of diabetes care devices, including glucose meters, insulin pumps, CGMs, and insulin pens, which are embedded into patient care protocols to support effective diabetes management.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$45.1 Billion
Forecast Value	$118.6 Billion
CAGR	11.4%

The North American diabetes care devices market is led by the U.S., which generated the highest revenue in 2023. The country's healthcare system is one of the most advanced globally, with significant investments in cutting-edge diabetes care technologies. The robust healthcare expenditure in the U.S. plays a key role in driving the adoption of these devices, as it enables access to state-of-the-art treatment options. Additionally, a favorable regulatory environment supports the development and approval of new diabetes care technologies, fostering innovation and growth within the market.

Overall, the diabetes care devices market is poised for significant growth, driven by the rising prevalence of diabetes, increasing awareness of effective management solutions, and the continued advancement of medical technology.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing prevalence of diabetes across the world
  - 3.2.1.2 Rising technological advancements in diabetes care devices
  - 3.2.1.3 Increasing investments by public and private organizations for diabetes care
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of diabetes care devices
  - 3.2.2.2 Rigorous regulatory framework
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Blood glucose monitoring devices
- 5.2.1 Self-monitoring blood glucose meters
- 5.2.2 Continuous glucose monitors
- 5.2.3 Testing strips
- 5.2.4 Lancets
5.3 Insulin delivery devices
- 5.3.1 Insulin pumps
  - 5.3.1.1 Tubed pumps
  - 5.3.1.2 Tubeless pumps
- 5.3.2 Pens
  - 5.3.2.1 Reusable
  - 5.3.2.2 Disposable
- 5.3.3 Pen needles
  - 5.3.3.1 Standard
  - 5.3.3.2 Safety
- 5.3.4 Syringes
- 5.3.5 Other insulin delivery devices

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital
6.3 Ambulatory surgical centres
6.4 Diagnostic centres
6.5 Homecare
6.6 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 France
- 7.3.3 UK
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.3.7 Sweden
- 7.3.8 Belgium
- 7.3.9 Denmark
- 7.3.10 Finland
- 7.3.11 Norway
- 7.3.12 Lithuania
- 7.3.13 Latvia
- 7.3.14 Estonia
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Colombia
- 7.5.5 Chile
- 7.5.6 Peru
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Turkey
- 7.6.5 Egypt
- 7.6.6 Israel
- 7.6.7 Kuwait
- 7.6.8 Qatar